20 related articles for article (PubMed ID: 15952082)
1. Interactions of estradiol and NSAIDS on carrageenan-induced hyperalgesia.
Hunter DA; Barr GA; Shivers KY; Amador N; Jenab S; Inturrisi C; Quinones-Jenab V
Brain Res; 2011 Mar; 1382():181-8. PubMed ID: 21281615
[TBL] [Abstract][Full Text] [Related]
2. The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms.
Barron AM; Verdile G; Martins RN
Endocrine; 2006 Apr; 29(2):257-69. PubMed ID: 16785601
[TBL] [Abstract][Full Text] [Related]
3. Effects of estrogen therapy of postmenopausal women on cytokines measured in peripheral blood.
Rogers A; Eastell R
J Bone Miner Res; 1998 Oct; 13(10):1577-86. PubMed ID: 9783546
[TBL] [Abstract][Full Text] [Related]
4. Effects of the natural and artificial menstrual cycle on the production of osteoprotegerin and the bone resorptive cytokines IL-1beta and IL-6.
Abrahamsen B; Stilgren LS; Rettmer E; Bonnevie-Nielsen V; Beck-Nielsen H
Calcif Tissue Int; 2003 Jan; 72(1):18-23. PubMed ID: 12384814
[TBL] [Abstract][Full Text] [Related]
5. Effect of estrogen/progesterone hormone replacement therapy on natural killer cell cytotoxicity and immunoregulatory cytokine release by peripheral blood mononuclear cells of postmenopausal women.
Stopińska-Głuszak U; Waligóra J; Grzela T; Głuszak M; Jóźwiak J; Radomski D; Roszkowski PI; Malejczyk J
J Reprod Immunol; 2006 Feb; 69(1):65-75. PubMed ID: 16236362
[TBL] [Abstract][Full Text] [Related]
6. Effects of hormone replacement therapy on plasma pro-inflammatory and anti-inflammatory cytokines and some bone turnover markers in postmenopausal women.
Vural P; Akgul C; Canbaz M
Pharmacol Res; 2006 Oct; 54(4):298-302. PubMed ID: 16879975
[TBL] [Abstract][Full Text] [Related]
7. Different effects of raloxifene and estrogen on interleukin-1beta and interleukin-1 receptor antagonist production using in vitro and ex vivo studies.
Rogers A; Clowes JA; Pereda CA; Eastell R
Bone; 2007 Jan; 40(1):105-10. PubMed ID: 16934544
[TBL] [Abstract][Full Text] [Related]
8. Effects of hormone replacement therapy on immunological factors in the postmenopausal period.
Abdi F; Mobedi H; Mosaffa N; Dolatian M; Ramezani Tehrani F
Climacteric; 2016 Jun; 19(3):234-9. PubMed ID: 27086591
[TBL] [Abstract][Full Text] [Related]
9. Effect of hormone replacement therapy on the production of bone-resorbing cytokines by peripheral blood cells in postmenopausal women.
Uemura H; Kamada M; Maegawa M; Ohmoto Y; Murata K; Kuwahara A; Matsuzaki T; Yasui T; Takeji T; Irahara M
Horm Metab Res; 2005 Apr; 37(4):226-30. PubMed ID: 15952082
[TBL] [Abstract][Full Text] [Related]
10. [Role of tumor necrosis factor (TNF) and interleukin-6 (IL-6) in the pathogenesis of late complications of menopause. Effects of hormone replacement therapy on TNF and IL-6 expression].
Rachoń D
Pol Merkur Lekarski; 2005 Jun; 18(108):724-7. PubMed ID: 16124393
[TBL] [Abstract][Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
